Healthy Skepticism Library item: 9010

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Nakagawa K.
[International clinical trials for a medical oncologist in Japan].
Gan To Kagaku Ryoho 2007 Feb; 34:(2):320-3
http://www.pier-online.jp/0385-0684/contents_abstract.php?serial_no=34020&seq=46

Abstract:

It is very important to participate into international clinical trials for cancer treatment not only for contribution to worldwide development of new anticancer agents but also for escape from social isolation out of new drug development. Here, we discussed about international clinical trials in Japan as an aspect of medical oncologist in medical school. And also, according to only one our experience of international clinical trial, IDEAL 1, which was a randomized phase II study of gefitinib for patients with previously treated metastatic non-small cell lung cancer, I tried to consider about current challenges of study investigators for cancer treatment, study conducting institution, pharmaceutical company, and regulatory agent in Japan.

Keywords:
Publication Types: English Abstract MeSH Terms: Antineoplastic Agents*/therapeutic use Clinical Trials*/trends Drug Industry/organization & administration Humans International Cooperation* Japan Medical Oncology*/manpower Medical Oncology*/trends Neoplasms/drug therapy Quinazolines/therapeutic use Substances: Antineoplastic Agents Quinazolines gefitinib

Notes:

Japanese.